1 / 16

Approach to Liver Function Test

Dr Yasir M Khayyat,MBcHB,FRCPC,FACP. Approach to Liver Function Test. Before you order LFT ask. 600 ريال. Hepatocellular Necrosis Markers. Markers of synthetic function. INR. Markers of Cholestasis. Liver cell. Liver cell. AST ALT. ALT: Specific from the liver ,Cytosolic Enzyme

blaise
Télécharger la présentation

Approach to Liver Function Test

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Khayyat Y Dr Yasir M Khayyat,MBcHB,FRCPC,FACP Approach to Liver Function Test

  2. Khayyat Y Before you order LFT ask 600 ريال

  3. Khayyat Y Hepatocellular Necrosis Markers Markers of synthetic function INR Markers of Cholestasis

  4. Khayyat Y Liver cell

  5. Khayyat Y Liver cell AST ALT

  6. ALT: • Specific from the liver ,Cytosolic Enzyme AST: • Muscle(skeletal , Cardiac),Brain,Kidney,Pancreas, cytoslic 20% and mitochondrial 80%. • Levels are normal in advanced cirrhosis AST/ALT ratio : • Acute liver injury ≤ 1 , Alcoholic hepatitis > 2 • Its elevation does not correlate with hepatic necrosis. Khayyat Y

  7. In Alcoholic liver disease AST  Alcohol increase release of mitochondrial AST ALT in alcohol there is pyridoxal 5 deficiency with decrease in ALT > AST activity In NAFLD,chronic liver disease: AST ( early low ,then with progressive disease and cirrhosis increase) , advanced cirrhosis  decrease hepatic clearance of AST. ALT Khayyat Y

  8. Alkaline phosphatase: • From Liver,Bone,Kidney,placenta,leukocytes,various neoplasms. • From the apical membrane of the hepatocyte and luminal domain of the bile duct. • Predominantly in infiltrative hepatic disorders, biliary obstruction ,extrahepatic biliary tree obstruction. • Due to increased de novo synthesis rather than release of the stored enzyme or impaired clearance GGT ( Gamma Glutamyl Transpeptidase) • From kidney,spleen,pancreas,heart,lung,brain Khayyat Y

  9. Bilirubin • Conjugated Bilirubin • Unconjugated Bilirubin Markers of Hepatic Synthesis: • INR or PT : • The liver is factory for all coagulation factors except 8. • INR if dependant on Vit K ( 2,7,9,10) • Increased in: vitamin K deficiency( malnutrition-malabsorption-antibiotic use)warfarin use, consumptive coagulpathy. Khayyat Y

  10. Albumin : • Synthesize 10g by the liver daily. It is not only reflect liver status but it reflects nutritional and volume status, vascular integrity,catabolism,hormonal factors, loss in the urine or stool. Khayyat Y

  11. Khayyat Y Non Hepatic causes of abnormal lft:

  12. Khayyat Y Hepatocellular necrosis

  13. Khayyat Y Cholestasis

  14. Khayyat Y

  15. Khayyat Y Hepatic granulomas

  16. Khayyat Y Think about the causes of liver disesase

More Related